Retrieval Versus Mid-luteal Endometrial Scratching (ES) for Intra Cytoplasmic Sperm Injection (ICSI) (ICSI)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03470298 |
|
Recruitment Status : Unknown
Verified March 2018 by Abd Elhady Zayed, Mansoura University.
Recruitment status was: Active, not recruiting
First Posted : March 19, 2018
Last Update Posted : March 19, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| ICSI | Procedure: Endometrial scratching | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 100 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | The patients in study undergo endometrial scratch technique after being randomly assigned in to one of two groups . First group undergo ES just after finishing oocyte pick up and the other group undergo ES one week before starting COH. Manual Vacuum Aspiration (MVA) size 5 moved from below upwards with suction ,scratching anterior uterine wall then posterior then left lateral uterine wall then right lateral uterine wall and lastly funds. |
| Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
| Primary Purpose: | Other |
| Official Title: | Retrieval Endometrial Scratching Versus Mid-luteal Endometrial Scratching for Women Undergoing ICSI for Unexplained Infertility |
| Actual Study Start Date : | January 1, 2017 |
| Estimated Primary Completion Date : | June 1, 2018 |
| Estimated Study Completion Date : | June 1, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Mid luteal Endometrial Scratching (MLES)
Making injury to endometrium by using Manual Vacuum Aspiration cannula size 5 . At this arm scratching done at mid luteal phase (day21) of the cycle before induction for ICSI
|
Procedure: Endometrial scratching
The patients in study undergo endometrial scratch technique after being randomly assigned in to one of two groups . First group undergo oocyte pickup just after finishing oocyte pick up and the other group undergo oocyte pickup one week before starting COH.ManualVaccum Aspiration (MVA) size 5 moved from below upwards with suction ,scrachning anterior uterine wall then posterior then left lateral uterine wall then right lateral uterine wall and lastly fundus. All patients were prescribed vibramycine 100 mg twice daily for 3 days starting one day before procedure
Other Name: Endometrial injury |
|
Active Comparator: Retrieval Endometrial Scratching (RES)
Making injury to endometrium by using Manual Vacuum Aspiration cannula size 5 .Here scratching done at same day of ovum pick up of ICSI cycle the difference only between arm of MLES and RES only in the timing of scratching .
|
Procedure: Endometrial scratching
The patients in study undergo endometrial scratch technique after being randomly assigned in to one of two groups . First group undergo oocyte pickup just after finishing oocyte pick up and the other group undergo oocyte pickup one week before starting COH.ManualVaccum Aspiration (MVA) size 5 moved from below upwards with suction ,scrachning anterior uterine wall then posterior then left lateral uterine wall then right lateral uterine wall and lastly fundus. All patients were prescribed vibramycine 100 mg twice daily for 3 days starting one day before procedure
Other Name: Endometrial injury |
- Live birth rate [ Time Frame: about 9 months ]delivery of a fetus after passing medico legal viability
- implantation rate [ Time Frame: 2 weeks after embryo transfer ]positive pregnancy test
- Clinical pregnancy rate [ Time Frame: 4 weeks after embryo transfer ]Appearance of gestational sac by ultrasound with fetal pole and cardiac pulsation
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 35 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with at least one previous failed ICSI cycles, Good responders in the previous ICSI cycle and Less than or equal to 35 years
Exclusion Criteria:. We excluded patients with; Presence of intramural fibroid distorting the endometrial cavity/sub mucous myoma/a Sherman's syndrome, Presence of son graphically detected hydrosalpinx, Patient age more than 35 years
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03470298
| Egypt | |
| Fertility care unite,Mansoura university hospital. | |
| Mansourah, Egypt | |
| Principal Investigator: | Abdelhady A Zayed, Ass. prof. | Mansoura university hospital ,Mansoura,Dakahlia,Egypt |
Study Data/Documents: Individual Participant Data Set

Publications:
| Responsible Party: | Abd Elhady Zayed, Associate professor of Obstetrics &Gynecology, Mansoura University |
| ClinicalTrials.gov Identifier: | NCT03470298 |
| Other Study ID Numbers: |
R/16.11.11 ABC123 ( Registry Identifier: Mansoura university ) |
| First Posted: | March 19, 2018 Key Record Dates |
| Last Update Posted: | March 19, 2018 |
| Last Verified: | March 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: | It is not yet decided if individual participant data will be available or not except after completion of study and counseling all persons sharing in the study . |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Endometrial Scratching Unexplained infertility ICSI |
|
Infertility |

